Updated survival analysis of preoperative gemcitabine (gem) plus bevacizumab (bev)-based chemoradiation for resectable pancreatic adenocarcinoma.
Rachna T. Shroff
No relevant relationships to disclose
Gauri R. Varadhachary
No relevant relationships to disclose
Christopher H. Crane
No relevant relationships to disclose
Jeffrey Edwin Lee
No relevant relationships to disclose
Jeffrey H. Lee
No relevant relationships to disclose
Linus Ho
No relevant relationships to disclose
Eric P. Tamm
No relevant relationships to disclose
Douglas B. Evans
No relevant relationships to disclose
James L. Abbruzzese
No relevant relationships to disclose
Robert A. Wolff
No relevant relationships to disclose